Introduction
Peripheral intravenous catheters (PIVCs) are the most commonly
used invasive device in hospitalised paediatric patients. They are primarily
used for therapeutic purposes such as administration of medications, fluids,
and blood products.
Aim
The aim of this guideline is to provide evidence-based
recommendations for the management of peripheral intravenous catheters (PIVCs),
including midlines and extended dwell PIVCs. For information related to PIVC
insertion, please refer to RCH
Clinical Practice Guideline: Intravenous access - peripheral.
Types of PIVCs
A peripheral intravenous catheter (PIVC) is
a thin plastic tube inserted into a vein using a needle. PIVCs allow for the
administration of medications, fluids and/or blood products. Some PIVCs have a
longer catheter length, which are usually inserted under ultrasound guidance. A
longer PIVC is referred to as an extended dwell PIVC.
Image
1: a peripheral intravenous catheter (PIVC); Illustration
by The Royal Children's Hospital, Melbourne
A midline is a type of peripheral intravenous
catheter which is usually between 5-10cm long and inserted into the brachial or
basilic veins in the upper arm. These devices are inserted by specially trained
practitioners. A midline is to be managed in the same way as a PIVC as the tip
of the device remains in the peripheral vasculature.
Image 2: a midline catheter *coming soon*
Definition of terms
- Aseptic technique aims to prevent pathogenic
microorganisms from being introduced to susceptible sites by hands, surfaces
and equipment. It is a set of practices designed to reduce contamination
and protect the patient from infection during invasive procedures such as
midline/PIVC insertion and maintenance. See procedure here.
- Key Parts are parts of the device/s that must
remain aseptic throughout the clinical procedures. Examples of key parts
include, the catheter hub, needleless connector, syringe hub and drawing up
needle.
- Key Sites are the area on the patient such as a
wound or intravenous insertion site that must be protected from microorganisms
- Scrub the hub ensure the needleless connector is
‘scrubbed’ vigorously with 2% chlorhexidine and 70% alcohol swab for 15 seconds
and allow for it to completely air dry.
- Hand Hygiene is performed to protect the patient
from organisms which may enter their key sites or key parts during a procedure.
See procedure here.
Assessment
Midline/PIVC
site assessment aims to:
- Ensure
early recognition of complications such as extravasation, phlebitis, occlusion
and device associated pressure injuries.
- Ensure the
dressing, catheter and attachments are intact and secure to prevent
dislodgement.
- Maintain
visibility of the insertion site.
How to perform midline/PIVC site assessment
Midline/PIVC
assessment is to include the ‘Touch, Look, Compare’ technique (TLC). Whenever
possible, cluster site assessment with other care.
-
Touch to assess the site is
soft, warm, dry and non-tender.
- Look to ensure the site is
dry and without redness. Ensure tapes are not too tight, there are no kinks in
the catheter and the insertion site is visible.
- Compare the
site with the other limb or side of the body. The site should be the same size,
without swelling.
Indications for midline/PIVC
removal:
With each assessment, also assess clinical
indication for ongoing access. If the patient no longer requires IV access,
remove the device as soon as clinically appropriate to avoid complications.
Caregiver and patient education:
Education should be provided on the signs of
injuries and the process of contacting nursing staff.
Frequency
of midline/PIVC assessment:
Risk
assessment
|
Frequency
of assessment
|
Critical care areas (paediatric intensive care unit
and neonatal intensive care unit)
|
At least
every hour.
|
For patients
receiving high-risk* medications, continuous infusions or large volume fluid
boluses
|
At least
every hour.
See table
below for list of high-risk medications.
|
Continuous IV fluid infusions (e.g., maintenance
fluid with no additives or TKVO)
|
At least every four hours.
|
Continuous IV fluid infusions with intermittent
medication administration
|
In addition to routine 4 hourly assessments
(as above), assess the midline/PIVC site before and after each
medication infusion.
|
Disconnected midlines/PIVCs
|
Every 8 hours. Whenever possible, try to
cluster assessments with cares.
|
Wallaby
(Hospital-in-the-Home) patients
|
The
nurse will assess the midline/PIVC with each visit. Families receive
education and support about checking midline/PIVC and communicating any
concerns.
|
Clinical condition changes
|
The
midline/PIVC site should be assessed if there is a change in the patient's condition, such as
clinical deterioration or any signs of discomfort or escalating requirements
for analgesics.
|
Documentation
- Midline/PIVC
site assessment and complications are to be documented in the LDA flowsheet row.
- The
volume of
fluid infused, and the infusion rate is documented in the fluid balance
flowsheet.
- Documentation occurs with each assessment.
Management of Midline/PIVC associated complications
Complication
|
Definition
|
Recognition
|
Management
|
Extravasation
(other common terms ‘tissued’ or ‘infiltration’)
|
Leaking of a fluid or medication into
extravascular tissue from a midline/PIVC with potential to cause short- or long-term
tissue damage.
|
Can present as pain, swelling, erythema,
induration, blistering, pallor, blanching or catheter dysfunction.
|
For assessment and management of extravasation
injuries, please see the Peripheral extravasation injuries initial
management and washout procedure CPG. |
Phlebitis
|
Is a sign
of vessel damage. The cause can be chemical (due to the osmolarity of the
solution), mechanical (from trauma at insertion or movement) or infective
(microorganisms contaminating the device). Signs include swelling, redness,
heat, induration, purulence or a palpable venous cord (hard vein). Symptoms
include pain related to local inflammation of the vein at or near the
insertion site.
|
Can range in
severity from slight pain and redness at the midline/PIVC insertion site to
severe erythema, pain, swelling, tenderness and signs of infection
(purulence, palpable vein cord).
|
If slight pain
and redness are present, closely monitor the PIVC insertion site (at least
hourly). If chemical phlebitis is suspected, consider altering the dilute of
the infusate or slowing down the infusion rate and assess if symptoms
resolve. If there is an increase in pain, redness and swelling, remove the
midline/PIVC. If severe phlebitis is present, consult the medical team as
additional intervention may be required.
|
Occlusion
|
Is characterised by the inability to flush or
administer fluid into the midline/PIVC.
|
Occlusion
occurs when there is mechanical dysfunction (e.g., a kink in the
catheter), a blockage (from blood components) or due to an extravasation
injury. All causes of occlusion may affect catheter patency.
|
Patency can be
evaluated by assessing response to infusing medication, ease of flushing, and
by performing a TLC assessment. If a kink in the external portion of the
catheter is visible, consider re-dressing the midline/PIVC. If catheter
patency is not restored, the midline/PIVC will need to be removed.
|
Dislodgment
|
Is the
unintended removal of the catheter out of the vein.
|
There may be
signs of midline/PIVC dysfunction (signs of occlusion or pain) and a portion
of, or the entire catheter will be visible.
|
Using sterile
gauze, apply pressure to the midline/PIVC insertion site (if bleeding) until
haemostasis is achieved.
|
Device associated pressure injuries
|
Occur when the midline/PIVC hub, extension set,
needleless connector or tapes are forced into the skin. Midline/PIVC
associated pressure injuries can cause varying degrees of harm including
superficial erythema to deep tissue damage.
|
May develop if any component of the midline/PIVC is
forced into the skin. Pain, erythema and skin breakdown may be present.
|
Regular and thorough TLC assessment may reduce the
risk of device associated pressure injury. TLC assessment is to include
observing for erythema with any of the device components and relieving
pressure by repositioning tapes or hard plastics (Pressure Injury Guideline)
|
*High
risk medications
Please see Peripheral Extravasation Injuries CPG for list of high risk medications.
Management of Midline/PIVC
Anytime a Midline/PIVC is accessed please ensure the following occurs:
- Scrub the hub, needless connector is ‘scrubbed’ vigorously with 2% chlorhexidine and 70% alcohol swab for 15 seconds and allow for it to completely air dry.
- Aseptic technique is utilised, see Aseptic technique procedure.
Infusion Pump Pressure
Pressure limit defaults for intravascular infusion pumps are
programmed by Biomedical Engineering, based on the manufacturer’s
recommendations.
Upper limit infusion pump pressure can be manually increased
with clinical discretion to accommodate:
- Increased viscosity of the fluid being
administered
- High rate of the fluid being administered
- Reduced diameter of the intravascular catheter
- Increased length of the intravascular catheter
- Increased level of patient activity
If pump pressure exceeds the
recommended limits, check the patency of the midline/PIVC.
Special consideration: Patients admitted to the Neonatal Unit should
have line pressure documented within the Peripheral IV Cannula Lines, Drains,
and Airway (LDA) tab.
Flushing and locking midlines/PIVCs
To keep vein open (TKVO)* is a continuous infusion of
fluid administered in-between medication(s). The infusion rate of TKVO usually
ranges from 1mL-10mL per hour. TKVO rates vary depending on the patients age,
weight and underlying condition.
Intermittent locking* refers to the administration of
a small volume (usually between 2-10mL) of 0.9% normal saline in-between
infusions and then disconnecting the infusion set from the midline/PIVC. The
volume of the lock should take into consideration the volume of the midline/PIVC,
and any add on devices. The lock is to be administered using a pulsatile
(push-pause) technique and if a clamp is present, it is to be closed under
positive pressure (i.e., whilst the lock is being administered).
*There is limited evidence available to guide practice on
the advantage of TKVO versus intermittent locking in patients who are not
receiving continuous medication or fluid. Intermittent locking may be the
preferred method for patients who are able to ambulate whilst receiving
intermittent intravenous treatment.
If the midline/PIVC is to be accessed intermittently for the
administration of medications or fluids, it is to be flushed prior to infusion
or at least once a shift
In most cases, 0.9% sodium chloride for injection is to be
used to flush the midline/PIVC. This must be prescribed as a medication
Use 10mL syringe for flushing to avoid excessive pressure
and catheter rupture. If resistance is felt during flushing and force is
applied this may result in an infiltration or extravasation injury
Use aseptic non touch techniques including cleaning the
access port (scrub the hub) vigorously for at least 15 seconds and allowing to
dry prior to accessing the system
When flushing or locking the midline/PIVC use a pulsatile
flushing technique (push pause motion)
Flush catheters:
- Before and after each infusion
- Immediately after placement
- Prior to and after fluid infusion (as an empty
fluid container lacks infusion pressure and will allow blood reflux into the
catheter lumen from normal venous pressure) or injection.
- Prior to and after blood drawing
Lock catheters:
- At the completion of an intermittent infusion;
- Close clamp or ensure 3-way tap is clamped.
Midline/PIVC dressings
Midline/PIVC dressings promote catheter security and prevent
infection as they provide a barrier to the external environment. PIVC dressings are to be kept secure, clean,
dry, intact and easily visible. The integrity of the dressing and all PIVC
components are to be assessed when preforming TLC.
There is no evidence available to suggest that routine PIVC
dressing changes are beneficial. Dressing changes are to occur when either the
insertion site or dressing are no longer secure, clean, dry and intact.
If the midline/PIVC requires a dressing change, consider the
risk of the procedure and determine if a standard or surgical aseptic technique
should be used.
Midline/PIVC removal
Midline/PIVC removal is to occur as soon as the device is no
longer required.
Using a standard aseptic technique, gently remove the old
dressing and then pull the catheter our of the skin whilst applying pressure
(with gauze) to the insertion site until haemostasis is achieved.
Document removal in the medical record.
Companion Documents
RCH Clinical Practice Guidelines
RCH Nursing Guidelines
RCH Policies and Procedures
Evidence Table
Updated evidence table coming soon.
The evidence table can be found here.
Please remember to read the
disclaimer.
The development of this nursing guideline was coordinated by Eloise Borello, CNC Vascular Assess Specialist Team approved by the Nursing Clinical Effectiveness Committee. Updated March 2025.